ArticleDrug safety2022

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports.

Corine Ekhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.